Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma Prince, RN, Michael J. Mack, MD The Annals of Thoracic Surgery Volume 99, Issue 4, Pages 1298-1305 (April 2015) DOI: 10.1016/j.athoracsur.2014.11.035 Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Time to first major adverse cardiac event (MACE) event in percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) patients; unmatched patients. The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Time to first major adverse cardiac event (MACE) event in percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) patients; matched patients. The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Time to first major adverse cardiac event (MACE) event in matched groups of drug eluting stents (DES) only and coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 4 Time to first major adverse cardiac event (MACE) event in insulin-dependent diabetics; percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions
Fig 5 Time to first major cardiac adverse event (MACE) in non-insulin dependent diabetics; percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG). The Annals of Thoracic Surgery 2015 99, 1298-1305DOI: (10.1016/j.athoracsur.2014.11.035) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions